ACE2 and cancer: The top cancers expressing ACE2 were from the gastrointestinal (colon, pancreas, stomach, and esophagus), and genitourinary tracts (kidney) with each of these cancers having increased rank expression compared to their matched normal tissue counterparts (Fig. 2, Supplementary Table S1).